NXEN (Nexien BioPharma) Interest Expense: $-0.07 Mil (TTM As of Mar. 2025)


What is Nexien BioPharma Interest Expense?

Nexien BioPharma NXEN Interest Expense is $-0.07 Mil as of Mar. 2025.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Nexien BioPharma's interest expense for the three months ended in Mar. 2025 was $ -0.02 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.07 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Nexien BioPharma's Operating Income for the three months ended in Mar. 2025 was $ -0.01 Mil. Nexien BioPharma's Interest Expense for the three months ended in Mar. 2025 was $ -0.02 Mil. Nexien BioPharma did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nexien BioPharma  (OTCPK:NXEN) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nexien BioPharma's Interest Expense for the three months ended in Mar. 2025 was $-0.02 Mil. Its Operating Income for the three months ended in Mar. 2025 was $-0.01 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was $0.00 Mil.

Nexien BioPharma's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Nexien BioPharma did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Nexien BioPharma Interest Expense Historical Data

* Premium members only.

The historical data trend for Nexien BioPharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexien BioPharma Interest Expense Chart

Nexien BioPharma Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Interest Expense
Get a 7-Day Free Trial 0.00 -0.02 -0.06 -0.08 -0.08

Nexien BioPharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.02 -0.02 -0.02 -0.02

Nexien BioPharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.07 Mil mean?
Nexien BioPharma (NXEN) has a Interest Expense of $-0.07 Mil as of Mar. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Nexien BioPharma and its competitors.
Is Nexien BioPharma's Interest Expense too high?
Nexien BioPharma's current Interest Expense is $-0.07 Mil.
How does Nexien BioPharma's Interest Expense compare to FLHLF and ZTS?
Nexien BioPharma's Interest Expense of $-0.07 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Nexien BioPharma and its competitors. Nexien BioPharma's current Interest Expense is $-0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexien BioPharma stock overvalued right now?
Nexien BioPharma (NXEN) has a current Interest Expense of $-0.07 Mil. The current Interest Expense is $-0.07 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Nexien BioPharma (NXEN), the current Interest Expense is $-0.07 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nexien BioPharma Business Description

Address 4340 East Kentucky Avenue, Suite 206, Glendale, CO, USA, 80246
Nexien BioPharma Inc is engaged in pre-clinical and drug development activities, by U.S. Food and Drug Administration (FDA) protocols, for certain pharmaceutical formulations that include cannabinoids. The company is pursuing the formulation and development of drugs containing cannabinoids for the treatment of various diseases, disorders, and medical conditions.